December 12 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its CEO Ognyan Donev has acquired 41,836 shares in the company at a weighted average price of 3.4461 levs ($1.96/1.76 euro) per share.
Donev acquired the shares in several transactions on the Bulgarian Stock Exchange on December 11, Sopharma said in a bourse filing.
The shares represent a 0.031% stake in Sopharma.
At the end of September, Donev held a stake of below 5% in Sopharma directly, according to the company's most recent interim financial statement.
Indirectly, Donev is the biggest shareholder in Sopharma, as he controls a 25.39% stake through his company Donev Investments Holding. Donev is also a major shareholder in Sopharma's second biggest shareholder - Telecomplect Invest. Telecomplect Invest controls 20.68% interest in Sopharma.
As at 9:30 CET on Thursday, Sopharma's shares traded 0.29% lower at 3.44 levs on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)